EUVIMEDEUVIMED entdecken
Crossref

CON: Patients With Recurrent Ovarian Carcinoma Should Not be Treated With Antiangiogenic Agents in Combination With Chemotherapy

Paul Sabbatini

Clinical Ovarian Cancer · 2011

DOI: 10.1016/j.cloc.2012.02.009 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Ovarian Cancer, 2011. Verfasst von Paul Sabbatini. Die Arbeit nennt 20 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Sabbatini, P. (2011). CON: Patients With Recurrent Ovarian Carcinoma Should Not be Treated With Antiangiogenic Agents in Combination With Chemotherapy. Clinical Ovarian Cancer. https://doi.org/10.1016/j.cloc.2012.02.009

Vancouver

Sabbatini P. CON: Patients With Recurrent Ovarian Carcinoma Should Not be Treated With Antiangiogenic Agents in Combination With Chemotherapy. Clinical Ovarian Cancer. 2011. doi:10.1016/j.cloc.2012.02.009

BibTeX
@article{Sabbatini2011,
  author = {Sabbatini, Paul},
  title = {CON: Patients With Recurrent Ovarian Carcinoma Should Not be Treated With Antiangiogenic Agents in Combination With Chemotherapy},
  journal = {Clinical Ovarian Cancer},
  year = {2011},
  doi = {10.1016/j.cloc.2012.02.009}
}
Kostenlos starten →